Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Boston Scientific Corp (BSX)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Boston Scientific Corp.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 885725.
Total stock buying since 2015: $9,656,193.
Total stock sales since 2015: $529,079,619.
Total stock option exercises since 2015: $72,235,199.
Table 3. Detailed insider trading at Boston Scientific Corp (BSX) , Part 6
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2019-12-02 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 6.28 | 31,400 |
| 2019-12-01 | Monson Jonathan (VP, Corp Controller and CAO) | Option Ex | 2,910 | .00 | 0 |
| 2019-12-01 | Wang Xin Warren (SVP and Pres, Asia Pacific) | Option Ex | 2,025 | .00 | 0 |
| 2019-12-01 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 11,472 | .00 | 0 |
| 2019-12-01 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 2,328 | .00 | 0 |
| 2019-11-27 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 20,552 | 43.27 | 889,326 |
| 2019-11-27 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 20,552 | 17.26 | 354,727 |
| 2019-11-26 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Sale | 22,487 | 42.70 | 960,262 |
| 2019-11-26 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 9,866 | 7.74 | 76,362 |
| 2019-11-20 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 4,800 | 42.58 | 204,393 |
| 2019-11-08 | Butcher Arthur C (SVP&Pres, Endoscopy) | Sale | 1,104 | 40.75 | 44,991 |
| 2019-11-04 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 9,623 | 41.66 | 400,894 |
| 2019-11-04 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 9,623 | 13.08 | 125,868 |
| 2019-11-01 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 42.05 | 210,250 |
| 2019-11-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 6.28 | 31,400 |
| 2019-10-03 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 9,623 | 39.25 | 377,741 |
| 2019-10-03 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 9,623 | 13.08 | 125,868 |
| 2019-10-02 | Brennan Daniel J. (EVP and CFO) | Sale | 20,462 | 39.44 | 807,041 |
| 2019-10-02 | Brennan Daniel J. (EVP and CFO) | Option Ex | 20,462 | 7.41 | 151,623 |
| 2019-10-01 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 41.14 | 205,685 |
| 2019-10-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 6.28 | 31,400 |
| 2019-09-03 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 42.50 | 212,500 |
| 2019-09-03 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 6.28 | 31,400 |
| 2019-08-29 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 34,035 | 42.65 | 1,451,422 |
| 2019-08-29 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 34,035 | 7.39 | 251,518 |
| 2019-08-15 | Butcher Arthur C (SVP&Pres, Endoscopy) | Sale | 6,329 | 41.98 | 265,678 |
| 2019-08-15 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 3,874 | 7.16 | 27,737 |
| 2019-08-13 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 12,000 | 42.79 | 513,516 |
| 2019-08-02 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 42.62 | 213,090 |
| 2019-08-02 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 6.28 | 31,400 |
| 2019-07-15 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 3,728 | 42.30 | 157,694 |
| 2019-07-01 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 43.41 | 217,049 |
| 2019-07-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 6.28 | 31,400 |
| 2019-07-01 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Sale | 20,673 | 43.41 | 897,414 |
| 2019-06-28 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Sale | 1,906 | 43.00 | 81,958 |
| 2019-06-17 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 3,039 | 40.46 | 122,957 |
| 2019-06-17 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 3,039 | 7.41 | 22,518 |
| 2019-06-04 | Pierce David A (EVP,Pres MedSurg) | Sale | 1,650 | 38.60 | 63,683 |
| 2019-06-03 | Wang Xin Warren (SVP and Pres, Asia Pacific) | Sale | 10,000 | 38.45 | 384,530 |
| 2019-06-03 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,140 | 38.45 | 197,648 |
| 2019-06-03 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,140 | 6.72 | 34,540 |
| 2019-06-01 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 1,761 | .00 | 0 |
| 2019-06-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 2,972 | .00 | 0 |
| 2019-05-29 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Sale | 22,047 | 38.03 | 838,425 |
| 2019-05-28 | Eddy Jodi Euerle (SVP and CIO) | Sale | 7,803 | 38.42 | 299,791 |
| 2019-05-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 3,038 | 36.74 | 111,616 |
| 2019-05-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 3,038 | 7.41 | 22,511 |
| 2019-05-05 | Wang Xin Warren (SVP and Pres, Asia Pacific) | Option Ex | 1,526 | .00 | 0 |
| 2019-05-01 | Mackey Edward F (EVP, Operations) | Sale | 55,320 | 36.83 | 2,037,324 |
| 2019-05-01 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 37.10 | 185,500 |
| 2019-05-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 7.16 | 35,800 |
| 2019-04-16 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 1,186 | 38.10 | 45,186 |
| 2019-04-15 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 2,011 | 37.81 | 76,035 |
| 2019-04-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 3,039 | 37.81 | 114,904 |
| 2019-04-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 3,039 | 7.41 | 22,518 |
| 2019-04-01 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 38.82 | 194,100 |
| 2019-04-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 7.16 | 35,800 |
| 2019-03-18 | Pierce David A (EVP,Pres MedSurg) | Sale | 14,739 | 39.47 | 581,718 |
| 2019-03-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 3,038 | 40.11 | 121,854 |
| 2019-03-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 3,038 | 7.41 | 22,511 |
| 2019-03-14 | Brennan Daniel J. (EVP and CFO) | Sale | 46,360 | 40.02 | 1,855,559 |
| 2019-03-12 | Carruthers Wendy (SVP, Human Resources) | Sale | 24,219 | 40.00 | 968,760 |
| 2019-03-12 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 24,219 | 7.39 | 178,978 |
| 2019-03-11 | Mackey Edward F (EVP, Operations) | Sale | 35,906 | 39.72 | 1,426,186 |
| 2019-03-11 | Carruthers Wendy (SVP, Human Resources) | Sale | 29,412 | 39.63 | 1,165,685 |
| 2019-03-11 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 29,412 | 7.47 | 219,707 |
| 2019-03-06 | Pierce David A (EVP,Pres MedSurg) | Sale | 1,357 | 40.25 | 54,619 |
| 2019-03-04 | Brennan Daniel J. (EVP and CFO) | Sale | 64,223 | 40.84 | 2,622,546 |
| 2019-03-03 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 3,302 | .00 | 0 |
| 2019-03-03 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 3,603 | .00 | 0 |
| 2019-03-02 | Mackey Edward F (EVP, Operations) | Option Ex | 19,226 | .00 | 0 |
| 2019-03-01 | Wang Xin Warren (SVP and Pres, Asia Pacific) | Sale | 10,000 | 40.31 | 403,060 |
| 2019-03-01 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Sale | 20,900 | 40.74 | 851,549 |
| 2019-03-01 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 40.34 | 201,680 |
| 2019-03-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 7.16 | 35,800 |
| 2019-02-28 | Eddy Jodi Euerle (SVP and CIO) | Option Ex | 1,425 | .00 | 0 |
| 2019-02-28 | Wang Xin Warren (SVP and Pres, Asia Pacific) | Option Ex | 1,629 | .00 | 0 |
| 2019-02-28 | Meredith Ian T (EVP Global Chief Med Officer) | Option Ex | 1,018 | .00 | 0 |
| 2019-02-28 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 1,527 | .00 | 0 |
| 2019-02-28 | Mackey Edward F (EVP, Operations) | Option Ex | 2,444 | .00 | 0 |
| 2019-02-28 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,833 | .00 | 0 |
| 2019-02-28 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,222 | .00 | 0 |
| 2019-02-28 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,480 | .00 | 0 |
| 2019-02-28 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,036 | .00 | 0 |
| 2019-02-28 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,629 | .00 | 0 |
| 2019-02-28 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,330 | .00 | 0 |
| 2019-02-28 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 2,444 | .00 | 0 |
| 2019-02-28 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,629 | .00 | 0 |
| 2019-02-26 | Pierce David A (EVP,Pres MedSurg) | Sale | 4,508 | 39.83 | 179,562 |
| 2019-02-21 | Butcher Arthur C (SVP&Pres, Endoscopy) | Sale | 15,225 | 39.95 | 608,238 |
| 2019-02-21 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 15,225 | 7.16 | 109,011 |
| 2019-02-20 | Pierce David A (EVP,Pres MedSurg) | Sale | 1,952 | 39.86 | 77,806 |
| 2019-02-15 | Eddy Jodi Euerle (SVP and CIO) | Option Ex | 922 | .00 | 0 |
| 2019-02-15 | Wang Xin Warren (SVP and Pres, Asia Pacific) | Option Ex | 1,384 | .00 | 0 |
| 2019-02-15 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 1,107 | .00 | 0 |
| 2019-02-15 | Meredith Ian T (EVP/ Global Chief Medical Officer) | Option Ex | 1,107 | .00 | 0 |
| 2019-02-15 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 1,845 | .00 | 0 |
| 2019-02-15 | Mackey Edward F (EVP, Operations) | Option Ex | 2,768 | .00 | 0 |
| 2019-02-15 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 1,845 | .00 | 0 |
| 2019-02-15 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 5,000 | 40.22 | 201,080 |
| 2019-02-15 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 6,199 | 6.54 | 40,541 |
| 2019-02-15 | Brennan Daniel J. (EVP and CFO) | Option Ex | 4,152 | .00 | 0 |
| 2019-02-15 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,030 | .00 | 0 |
| 2019-02-15 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 3,229 | .00 | 0 |
| 2019-02-15 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 1,661 | .00 | 0 |
| 2019-02-15 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 18,456 | .00 | 0 |
| 2019-02-15 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 2,768 | .00 | 0 |
| 2019-02-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 3,039 | 40.32 | 122,532 |
| 2019-02-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 4,700 | 3.71 | 17,413 |
| 2019-02-15 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 4,614 | .00 | 0 |
| 2019-02-14 | Brennan Daniel J. (EVP and CFO) | Sale | 22,438 | 39.57 | 887,916 |
| 2019-02-12 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Sale | 44,236 | 40.00 | 1,769,440 |
| 2019-02-12 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 44,236 | 8.30 | 367,158 |
| 2019-02-01 | Meredith Ian T (EVP/ Global Chief Medical Officer) | Option Ex | 3,130 | .00 | 0 |
| 2019-02-01 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 38.15 | 190,750 |
| 2019-02-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 7.16 | 35,800 |
| 2019-01-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 3,038 | 35.46 | 107,727 |
| 2019-01-15 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 3,038 | 7.41 | 22,511 |
| 2019-01-09 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Sale | 4,047 | 36.00 | 145,692 |
| 2019-01-09 | Pierce David A (EVP,Pres MedSurg) | Sale | 10,319 | 35.67 | 368,078 |
| 2019-01-08 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 35.00 | 175,000 |
| 2019-01-08 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 7.16 | 35,800 |
| 2019-01-03 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Sale | 14,740 | 33.88 | 499,420 |
| 2019-01-02 | Eddy Jodi Euerle (SVP and CIO) | Option Ex | 2,099 | .00 | 0 |
| 2019-01-01 | Mackey Edward F (EVP, Operations) | Option Ex | 16,540 | .00 | 0 |
| 2019-01-01 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 11,578 | .00 | 0 |
| 2019-01-01 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 9,097 | .00 | 0 |
| 2019-01-01 | Brennan Daniel J. (EVP and CFO) | Option Ex | 33,081 | .00 | 0 |
| 2019-01-01 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 13,232 | .00 | 0 |
| 2019-01-01 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 21,502 | .00 | 0 |
| 2019-01-01 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 13,232 | .00 | 0 |
| 2019-01-01 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 132,328 | .00 | 0 |
| 2019-01-01 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 14,885 | .00 | 0 |
| 2019-01-01 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 10,750 | .00 | 0 |
| 2019-01-01 | Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt) | Option Ex | 23,157 | .00 | 0 |
| 2018-12-03 | Wang Xin Warren (SVP and Pres, Asia Pacific) | Sale | 10,000 | 38.00 | 379,990 |
| 2018-12-03 | Pierce David A (EVP,Pres MedSurg) | Sale | 5,000 | 38.12 | 190,575 |
| 2018-12-03 | Pierce David A (EVP,Pres MedSurg) | Option Ex | 5,000 | 7.16 | 35,800 |
| 2018-12-01 | Wang Xin Warren (SVP and Pres, Asia Pacific) | Option Ex | 2,025 | .00 | 0 |
| 2018-12-01 | Ralls-morrison Desiree (SVP, GC and Corp Secretary) | Option Ex | 11,472 | .00 | 0 |
| 2018-12-01 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 2,327 | .00 | 0 |
| 2018-11-30 | Fujimori Yoshiaki (Director) | Sale | 6,143 | 37.13 | 228,089 |
| 2018-11-29 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Sale | 15,298 | 36.74 | 562,017 |
| 2018-11-16 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Sale | 23,458 | 37.28 | 874,443 |
| 2018-11-16 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 23,458 | 8.30 | 194,701 |
| 2018-11-09 | Butcher Arthur C (SVP&Pres, Endoscopy) | Sale | 4,000 | 38.50 | 154,000 |
| 2018-11-09 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Sale | 23,458 | 37.51 | 879,886 |
| 2018-11-09 | Thepaut Eric Francis Yves (SVP & Pres, Eur, Mid-East, Afr) | Option Ex | 23,458 | 8.30 | 194,701 |
| 2018-11-02 | Carruthers Wendy (SVP, Human Resources) | Sale | 1,500 | 36.64 | 54,964 |
| 2018-11-01 | Mahoney Michael F (Chairman, President & CEO) | Sale | 116,666 | 36.35 | 4,240,692 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BSX listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Boston Scientific Corp (symbol BSX,
CIK number 885725) see
the Securities and Exchange Commission (SEC) website.